BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16004186)

  • 1. Should hormesis be the default model in risk assessment?
    Calabrese EJ
    Hum Exp Toxicol; 2005 May; 24(5):243. PubMed ID: 16004186
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormesis and toxicological risk assessment.
    Rodricks JV
    Toxicol Sci; 2003 Feb; 71(2):134-6. PubMed ID: 12563098
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: hormesis and ecological risk assessment.
    Rand GM
    Hum Exp Toxicol; 2001 Oct; 20(10):525-6; discussion 529-31. PubMed ID: 11858516
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormesis--does it have relevance at the population, community or ecosystem levels of organization?
    Giesy JP
    Hum Exp Toxicol; 2001 Oct; 20(10):517-20; discussion 529-31. PubMed ID: 11858514
    [No Abstract]   [Full Text] [Related]  

  • 5. Precaution, institutions, incentives, heuristics, regulation and hormesis: comments on 'Hormesis in precautionary regulatory culture: models preferences and the advancement of science'.
    Morris J
    Hum Exp Toxicol; 2007 Nov; 26(11):851-3; discussion 875-6. PubMed ID: 18042579
    [No Abstract]   [Full Text] [Related]  

  • 6. The implications of hormesis to ecotoxicology and ecological risk assessment.
    Chapman PM
    Hum Exp Toxicol; 2001 Oct; 20(10):499-505. PubMed ID: 11858510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormesis in precautionary regulatory culture: models preferences and the advancement of science.
    Hanekamp JC; Bast A
    Hum Exp Toxicol; 2007 Nov; 26(11):855-73. PubMed ID: 18042580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much is enough to accept hormesis as the default? or 'At what point, if ever, could/should hormesis be employed as the principal dose-response default assumption in risk assessment?'.
    Jayjock MA
    Hum Exp Toxicol; 2005 May; 24(5):245-7. PubMed ID: 16004187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormesis: the new approach in risk assessment?
    Christiani DC; Zhou W
    Hum Exp Toxicol; 2002 Jul; 21(7):399-400. PubMed ID: 15497239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the risks and benefits of replacing traditional dose-response with hormesis.
    Pickrell JA; Oehme FW
    Hum Exp Toxicol; 2005 May; 24(5):259-64. PubMed ID: 16004190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormesis: how it could affect the risk assessment process.
    Calabrese EJ; Cook RR
    Hum Exp Toxicol; 2005 May; 24(5):265-70. PubMed ID: 16004191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormesis: the dose-response revolution.
    Calabrese EJ; Baldwin LA
    Annu Rev Pharmacol Toxicol; 2003; 43():175-97. PubMed ID: 12195028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response.
    Weltje L; vom Saal FS; Oehlmann J
    Hum Exp Toxicol; 2005 Sep; 24(9):431-7. PubMed ID: 16235731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormesis in ecological risk assessment: a useful concept, a confusing term, and/or a distraction?
    Menzie CA
    Hum Exp Toxicol; 2001 Oct; 20(10):521-3; discussion 529-31. PubMed ID: 11858515
    [No Abstract]   [Full Text] [Related]  

  • 15. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The no-observed-adverse-effect-level in drug safety evaluations: use, issues, and definition(s).
    Dorato MA; Engelhardt JA
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):265-74. PubMed ID: 15979222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hormetic dose-response model is more common than the threshold model in toxicology.
    Calabrese EJ; Baldwin LA
    Toxicol Sci; 2003 Feb; 71(2):246-50. PubMed ID: 12563110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Econonic implications of hormesis: some additional thoughts.
    Smith VK; Evans MF
    Hum Exp Toxicol; 2004 Jun; 23(6):285-7; discussion 303-5. PubMed ID: 15301155
    [No Abstract]   [Full Text] [Related]  

  • 19. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecological risk assessment (ERA) and hormesis.
    Chapman PM
    Sci Total Environ; 2002 Apr; 288(1-2):131-40. PubMed ID: 12013541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.